Pediatrix Medical Group Non-GAAP EPS of $0.67 beats by $0.20, revenue of $492.9M beats by $16.46M

* Pediatrix Medical Group press release [https://seekingalpha.com/pr/20289361-pediatrix-medical-group-reports-third-quarter-results] (MD [https://seekingalpha.com/symbol/MD]): Q3 Non-GAAP EPS of $0.67 beats by $0.20.
* Revenue of $492.9M (-3.6% Y/Y) beats by $16.46M.
* This decrease reflects the impact of non-same unit activity, primarily practice dispositions, partially offset by growth in same-unit net revenue of 8.0 percent.
* Pediatrix is raising its full year 2025 outlook for Adjusted EBITDA, as defined above, and now anticipates Adjusted EBITDA will likely be in a range of $270 million to $290 million.

MORE ON PEDIATRIX MEDICAL GROUP

* Pediatrix Medical Group, Inc. (MD) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4808766-pediatrix-medical-group-inc-md-q2-2025-earnings-call-transcript]
* Pediatrix Medical Group announces $250M share repurchase program [https://seekingalpha.com/news/4486748-pediatrix-medical-group-announces-250m-share-repurchase-program]
* Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens [https://seekingalpha.com/news/4478609-pediatrix-raises-2025-adjusted-ebitda-guidance-to-245m-255m-as-nicu-days-climb-6-percent-and]
* Seeking Alpha’s Quant Rating on Pediatrix Medical Group [https://seekingalpha.com/symbol/MD/ratings/quant-ratings]
* Historical earnings data for Pediatrix Medical Group [https://seekingalpha.com/symbol/MD/earnings]